Heuron Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
38
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
12
Heuron General Information
Description
Developer of an artificial intelligence-based image analysis medical device intended for neurological disease diagnosis. The company offers magnetic resonance imaging (MRI) diagnosis software for rapid and accurate medical response by implementing the diagnostic logic of professional clinicians into an AI model, enabling medical professionals to facilitate the accurate and early diagnosis of Alzheimer's and Parkinson's disease with early diagnosis, staging, traceability and identifying brain damage levels.
Contact Information
Website
www.iheuron.comCorporate Office
- 10th Floor, Building C, 150 Yeongdeungpo-ro, Yeongdeungpo-gu
- Dangsan-dong 1-ga, Saenggak Factory Dangsan
- Seoul, 07292
- South Korea
Corporate Office
- 10th Floor, Building C, 150 Yeongdeungpo-ro, Yeongdeungpo-gu
- Dangsan-dong 1-ga, Saenggak Factory Dangsan
- Seoul, 07292
- South Korea
Heuron Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 29-May-2025 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 01-Sep-2024 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 30-May-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 21-Jul-2020 | $12.7M | $15.4M | Completed | Generating Revenue | |
| 1. Seed Round | 07-Apr-2019 | $2.64M | $2.64M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Heuron Patents
Heuron Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260050053-A1 | Method for simultaneous imaging and image processing of neuromelanin and nigrosome 1 using 3d multi-echo gre | Pending | 16-Aug-2024 | ||
| JP-2025066635-A | Large vessel occlusion test device and method using eyeball deviation | Active | 11-Oct-2023 | ||
| US-12193744-B1 | Large vessel occlusion test device and method using eyeball deviation | Active | 11-Oct-2023 | ||
| JP-2025009651-A | Apparatus and method for extracting vascular function from brain-related information | Active | 04-Jul-2023 | ||
| US-12026883-B1 | Apparatus and method for extracting vascular function from brain-related information | Active | 04-Jul-2023 | G06T7/0012 |
Heuron Signals
Heuron Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedTech Innovator | Accelerator/Incubator | |||
| Positive Investment | Venture Capital | Minority | ||
| SBVA | Venture Capital | Minority | ||
| Y&Archer | Accelerator/Incubator | Minority | ||
| CNT Tech | Accelerator/Incubator | Minority |
Heuron FAQs
-
When was Heuron founded?
Heuron was founded in 2017.
-
Where is Heuron headquartered?
Heuron is headquartered in Seoul, South Korea.
-
What is the size of Heuron?
Heuron has 38 total employees.
-
What industry is Heuron in?
Heuron’s primary industry is Other Healthcare Technology Systems.
-
Is Heuron a private or public company?
Heuron is a Private company.
-
What is Heuron’s current revenue?
The current revenue for Heuron is .
-
How much funding has Heuron raised over time?
Heuron has raised $28.7M.
-
Who are Heuron’s investors?
MedTech Innovator, Positive Investment, SBVA, Y&Archer, and CNT Tech are 5 of 12 investors who have invested in Heuron.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process